SCHEMBL27190074

SCHEMBL27190074

O=[N+]([O-])c1ccc2c(Cl)c(C3CC3)cnc2c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.44
MAPT P10636 7/20 0.44
TDP1 Q9NUW8 7/20 0.44
MEN1 O00255 6/20 0.44
KMT2A Q03164 6/20 0.44
HTT P42858 4/20 0.44
LMNA P02545 4/20 0.44
PKM P14618 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
ALDH1A1 P00352 7/20 0.42
CTSB P07858 5/20 0.42
IDO1 P14902 2/20 0.42
TDO2 P48775 2/20 0.42
GAA P10253 1/20 0.42
HSP90AA1 P07900 2/20 0.41
OPRK1 P41145 2/20 0.41
GPR35 Q9HC97 2/20 0.39
CASP6 P55212 2/20 0.39
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27190052 0.82 KDM4E (0.51) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL30122585 0.82 MAPT (0.36) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL24715822 0.81 MAPT (0.39) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL27190036 0.76 MAPT (0.48) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL30122596 0.75 HSP90AA1 (0.45) KDM4EMAPTTDP1LMNAPKM
SCHEMBL27190162 0.74 MAPT (0.46) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL27190090 0.74 MEN1 (0.47) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL27190089 0.73 KMT2A (0.67) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL27190046 0.72 KDM4E (0.61) KDM4EMAPTTDP1MEN1KMT2A
SCHEMBL27190051 0.71 KDM4E (0.45) KDM4EMAPTTDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 EP disclosed
CN-120035438-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2025-05-23 CN disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
WO-2024109684-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE 江苏亚虹医药科技股份有限公司 2024-05-30 WO disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 KDM4E 2921/4885MAPT 4416/4885TDP1 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.